✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Zim Laboratories Ltd.

ZIMLAB

Market Cap
₹663 Cr.
P/E
113.60

Zim Laboratories Ltd.

  • Zim Laboratories
  • Kilitch Drugs(India)
  • Anuh Pharma
  • TJI Pharma - Small Cap

FAQs on Zim Laboratories Ltd. Shareprice

Zim Laboratories has given lower returns compared to its competitors.
Zim Laboratories has grown at ~12.22% over the last 4yrs while peers have grown at a median rate of 21.0%

Yes, Zim Laboratories is expensive.
Latest PE of Zim Laboratories is 113, while 3 year average PE is 33.36.
Also latest EV/EBITDA of Zim Laboratories is 24.74 while 3yr average is 12.29.

View FAQ's On Business

Growth Table

  • Zim Laboratories Ltd.
  • Kilitch Drugs(India)
  • Anuh Pharma

Balance Sheet

  • Zim Laboratories Ltd.
  • Kilitch Drugs(India)
  • Anuh Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Zim Laboratories Ltd.
  • Kilitch Drugs(India)
  • Anuh Pharma

Cash Flow

  • Zim Laboratories Ltd.
  • Kilitch Drugs(India)
  • Anuh Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Zim Laboratories Ltd.
  • Kilitch Drugs(India)
  • Anuh Pharma

Quarterly Results

  • Zim Laboratories Ltd.
  • Kilitch Drugs(India)
  • Anuh Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Zim Laboratories Ltd. Financials

Balance sheet of Zim Laboratories is strong.
But short term working capital might become an issue for this company.

The net debt of Zim Laboratories is decreasing.
Latest net debt of Zim Laboratories is ₹36.03 Crs as of Mar-26.
This is less than Mar-25 when it was ₹107 Crs.

No, profit is decreasing.
The profit of Zim Laboratories is ₹5.84 Crs for Mar 2026, ₹12.17 Crs for Mar 2025 and ₹17.25 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Zim Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech